⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5879487 | 0.72 | — | — | |
| SCHEMBL27554893 | 0.70 | — | — | |
| SCHEMBL10648653 | 0.67 | — | — | |
| SCHEMBL7244889 | 0.65 | CA12 (0.38) | — | |
| SCHEMBL7199305 | 0.65 | — | — | |
| SCHEMBL8258247 | 0.64 | — | — | |
| SCHEMBL260629 | 0.64 | — | — | |
| SCHEMBL6750229 | 0.62 | — | — | |
| SCHEMBL6750234 | 0.62 | — | — | |
| SCHEMBL13531645 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203491-A1 | DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR TREATING COVID-19 CONTAINING SAME | SIRNAGEN THERAPEUTICS CORPORATION (KR) | 2023-06-29 | — | — | US | claimed |
| EP-4183879-A1 | DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR TREATING COVID-19 CONTAINING SAME | Bioneer Corporation (KR) | 2023-05-24 | — | — | EP | claimed |
| WO-2020149644-A1 | DOUBLE-STRANDED OLIGONUCLEOTIDE TARGETING DKK1 GENE, CONSTRUCT INCLUDING SAME, AND HAIR LOSS PREVENTION OR HAIR GROWTH COMPOSITION CONTAINING SAME | (주)바이오니아 | 2020-07-23 | — | — | WO | claimed |
| CN-104011020-A | Use Of Photocleavable Compounds | FEMTONICS KFT | 2014-08-27 | — | — | CN | claimed |
| CN-102105437-B | Adamantyl diamide derivatives and uses of same | LUNDBECK & CO AS H | 2014-07-23 | — | — | CN | claimed |
| CN-101445469-B | Inhibitors of histone deacetylase | METHYLGENE INC | 2013-02-13 | — | — | CN | claimed |
| CN-102105437-A | Adamantyl diamide derivatives and uses of same | LUNDBECK & CO AS H | 2011-06-22 | — | — | CN | claimed |
| CN-1863774-B | Compounds and compositions as protein kinase inhibitors | IRM LLC | 2010-12-15 | — | — | CN | claimed |
| CN-101687869-A | Tetracyclic lactam derivatives as MK2 inhibitors | NOVARTIS AG | 2010-03-31 | — | — | CN | claimed |
| CN-101445469-A | Inhibitors of histone deacetylase | METHYLGENE INC (CA) | 2009-06-03 | — | — | CN | claimed |
| CN-1798721-A | Cyclohexyl derivatives as selective estrogen receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2006-07-05 | — | — | CN | claimed |
| EP-1198592-A4 | OLIGONUCLEOTIDES INCORPORATING BOTH 2-AMINOADENINE AND 5-SUBSTITUTED PYRIMIDINES | ISIS PHARMACEUTICALS INC (US) | 2002-09-18 | — | — | EP | claimed |
| EP-1224280-A2 | DESIGN OF HIGH AFFINITY RNASE H RECRUITING OLIGONUCLEOTIDE | Exiqon A/S (DK) | 2002-07-24 | — | — | EP | claimed |
| EP-1198592-A1 | OLIGONUCLEOTIDES INCORPORATING BOTH 2-AMINOADENINE AND 5-SUBSTITUTED PYRIMIDINES | ISIS PHARMACEUTICALS, INC. (US) | 2002-04-24 | — | — | EP | claimed |
| EP-1109825-A4 | IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES INCORPORATING 2-AMINOADENOSINE | ISIS PHARMACEUTICALS INC (US) | 2001-09-05 | — | — | EP | claimed |
| EP-1109825-A1 | IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES INCORPORATING 2-AMINOADENOSINE | ISIS PHARMACEUTICALS, INC. (US) | 2001-06-27 | — | — | EP | claimed |
| WO-2001025248-A2 | DESIGN OF HIGH AFFINITY RNASE H RECRUITING OLIGONUCLEOTIDE | EXIQON A/S (DK) | 2001-04-12 | — | — | WO | claimed |
| US-6175004-B1 | REACTING AN OLIGONUCLEOTIDE COMPRISING A HALOGENATED PURINE NUCLEOSIDE WITH AMINE; FOR STRONGER HYBRIDIZATION; DIAGNOSIS; GENETIC ENGINEERING; ANTISENSE AGENTS | ISIS PHARMACEUTICALS, INC. | 2001-01-16 | — | — | US | claimed |
| WO-2001002608-A1 | OLIGONUCLEOTIDES INCORPORATING BOTH 2-AMINOADENINE AND 5-SUBSTITUTED PYRIMIDINES | ISIS PHARMACEUTICALS, INC. (US) | 2001-01-11 | — | — | WO | claimed |
| WO-2000012563-A1 | IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES INCORPORATING 2-AMINOADENOSINE | ISIS PHARMACEUTICALS, INC. (US) | 2000-03-09 | — | — | WO | claimed |